U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07092865) titled 'A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant' on July 23.
Brief Summary: This study evaluates persistence of the immune response of the adjuvanted RSV vaccine and the safety and immunogenicity following revaccination in adults 18 years of age and above who received lung or kidney transplant.
Study Start Date: Aug. 06
Study Type: INTERVENTIONAL
Condition:
Respiratory Syncytial Virus Infections
Intervention:
BIOLOGICAL: Adjuvante...